Document

blob:https://www.fdms.gov/274701c8-a5f5-4beb-a07e-1cacf1c78741

ICR 202611-0938-001 · OMB 0938-1078 · Object 174827100.

Document Viewer [pdf]

Status: Original and derived artifacts are available for this document.

Download: pdf

Primary: pdfSource: application/pdf
Loading document viewer…

Document Metadata

Record metadata
application/pdf
blob:https://www.fdms.gov/274701c8-a5f5-4beb-a07e-1cacf1c78741
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KH
2026-08-22
2026-08-22
complete

Extracted Text

8/22/26, 11:14 AM

blob:https://www.fdms.gov/274701c8-a5f5-4beb-a07e-1cacf1c78741

PUBLIC SUBMISSION

As of: 8/22/26, 11:14 AM
Received: August 10, 2026
Status: Posted
Posted: August 22, 2026
Category: Academic - OT005
Tracking No. msn-q3wh-ntwi
Comments Due: August 10, 2026
Submission Type: Web

Docket: CMS-2026-2180
Collection Requirements for Compendia for Determination of Medically-accepted Indications for Offlabel Uses of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen (CMS-10302)
Comment On: CMS-2026-2180-0001
Collection Requirements for Compendia for Determination of Medically-accepted Indications for Offlabel Uses of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen (CMS-10302)
Document: CMS-2026-2180-0002
Comment on CMS-2026-2180-0001

Submitter Information
Email: [email protected]
Organization: Main Street Foundation Center for Regulatory Analysis and Engagement

General Comment
Attached are comments from the Main Street Foundation Center for Regulatory Analysis and
Engagement.

Attachments
MSF CRAE HHS CMS Comments Off Label Compendia FINAL 081026

blob:https://www.fdms.gov/274701c8-a5f5-4beb-a07e-1cacf1c78741

1/1